ARTICLE | Financial News
The Medicines Co. prices IPO
August 7, 2000 7:00 AM UTC
MDCO, which acquires, develops and commercializes biopharmaceuticals in late stage development, priced its IPO at $16. On July 3, the company filed to sell 5 million shares at $14-$16, after originall...